Press – Maiwald

Press Coverage

12 Feb 2025 - Press Coverage

Royalty Pharma Announces $250M R&D Funding Collaboration with Biogen

New York, NY, February 12, 2025 – Royalty Pharma (Nasdaq: RPRX) has entered into an agreement with Biogen to provide up to $250 million in research and development (R&D) funding for litifilimab, a first-in-class investigational biologic in Phase 3 tria...

28 Nov 2024 - Press Coverage

Swerving the matter of granting genetic scissor patents at the EPO

The European Patent Office (EPO) was expected to issue key rulings on CRISPR/Cas9 patents this autumn, but instead, legal uncertainty persists. Nobel Prize winners Emmanuelle Charpentier and Jennifer Doudna, pioneers of the technology, withdrew their patent applications befo...

30 Oct 2024 - Press Coverage

PI decision at UPC local division Munich after withdrawal of the PI request

The article sheds light on preliminary injunction proceedings before the local division of the Unified Patent Court (UPC) in Munich between the applicant Tiroler Rohre (TRM) and the defendants SSAB Swedish Steel GmbH and SSAB Europe Oy concerning pile shoes for anchoring str...

All press coverage

Maiwald press releases

11 Aug 2023 - Press Release

Another success for Maiwald and betapharm Arzneimittel GmbH

We are happy to report that the oppositions filed by our client betapharm and eight other generics manufacturers against Novartis patent EP 3 351 246 were successful; the Board of Appeal of the European Patent Office revoked the Novartis patent for lack of inventive step (fi...

20 Dec 2022 - Press Release

Maiwald wins important opposition case for its client Acetate International LLC at the European Patent Office

Maiwald GmbH in Munich has achieved an important victory for its client Acetate International LLC at the European Patent Office. Acetate International LLC is part of the Celanese group which has a long history of producing cellulose acetate products for commercial applicatio...

11 Oct 2022 - Press Release

Law firm will in future operate as Maiwald GmbH

Munich, 11 October 2022 - Maiwald, one of Germany's largest and most renowned law firms in the field of intellectual property, will in future operate under a new name: Effective October 11, 2022, Maiwald Patentanwaltsgesellschaft und Rechtsanwaltsgesellschaft mbH changed its...

All press releases

Maiwald in the press